Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587M Sell
1,478,788
-907,025
-38% -$258M 0.05% 312
2026
Q1
$414M Buy
2,385,813
+152,683
+7% +$31.3M 0.04% 390
2025
Q4
$572M Buy
2,233,130
+189,670
+9% +$49.7M 0.05% 271
2025
Q3
$532M Buy
2,043,460
+25,938
+1% +$6.82M 0.08% 275
2025
Q2
$493M Sell
2,017,522
-231,719
-10% -$57.8M 0.08% 287
2025
Q1
$595M Sell
2,249,241
-148,567
-6% -$40.2M 0.11% 215
2024
Q4
$608M Buy
2,397,808
+550,692
+30% +$148M 0.11% 204
2024
Q3
$585M Buy
1,847,116
+242,068
+15% +$86.2M 0.11% 205
2024
Q2
$600M Buy
1,605,048
+5,112
+0.3% +$1.73M 0.13% 169
2024
Q1
$555M Buy
1,599,936
+549,244
+52% +$208M 0.12% 200
2023
Q4
$481M Buy
1,050,692
+85,204
+9% +$42M 0.11% 218
2023
Q3
$470M Buy
965,488
+13,670
+1% +$6.42M 0.13% 194
2023
Q2
$426M Sell
951,818
-253,340
-21% -$128M 0.11% 230
2023
Q1
$585M Sell
1,205,158
-92,370
-7% -$45.7M 0.16% 140
2022
Q4
$665M Buy
1,297,528
+223,302
+21% +$117M 0.19% 108
2022
Q3
$521M Buy
1,074,226
+240,833
+29% +$117M 0.17% 134
2022
Q2
$390M Buy
833,393
+309,673
+59% +$138M 0.12% 210
2022
Q1
$228M Sell
523,720
-10,245
-2% -$4.29M 0.06% 450
2021
Q4
$248M Buy
533,965
+26,414
+5% +$11.7M 0.06% 434
2021
Q3
$198M Sell
507,551
-98,935
-16% -$42M 0.05% 504
2021
Q2
$269M Sell
606,486
-20,140
-3% -$8.8M 0.07% 377
2021
Q1
$263M Sell
626,626
-115,601
-16% -$46.1M 0.07% 362
2020
Q4
$305M Buy
742,227
+21,470
+3% +$8.93M 0.09% 272
2020
Q3
$298M Sell
720,757
-81,377
-10% -$32.7M 0.1% 234
2020
Q2
$311M Buy
802,134
+6,167
+0.8% +$2.31M 0.11% 214
2020
Q1
$250M Sell
795,967
-39,718
-5% -$13.4M 0.11% 229
2019
Q4
$306M Sell
835,685
-112,408
-12% -$35.7M 0.1% 264
2019
Q3
$242M Buy
948,093
+257,391
+37% +$72.2M 0.06% 365
2019
Q2
$183M Sell
690,702
-57,298
-8% -$14.5M 0.05% 455
2019
Q1
$199M Sell
748,000
-276,842
-27% -$79.8M 0.07% 339
2018
Q4
$294M Buy
1,024,842
+278,920
+37% +$88.4M 0.11% 205
2018
Q3
$253M Sell
745,922
-68,422
-8% -$22.2M 0.08% 267
2018
Q2
$242M Buy
814,344
+98,161
+14% +$28.7M 0.08% 276
2018
Q1
$193M Buy
716,183
+79,234
+12% +$21.5M 0.07% 292
2017
Q4
$158M Sell
636,949
-336,148
-35% -$83M 0.06% 349
2017
Q3
$237M Buy
973,097
+16,396
+2% +$4.02M 0.09% 263
2017
Q2
$230M Buy
956,701
+474,270
+98% +$107M 0.07% 279
2017
Q1
$99.4M Buy
482,431
+107,583
+29% +$22.2M 0.03% 508
2016
Q4
$76.5M Buy
374,848
+198,240
+112% +$37.8M 0.03% 609
2016
Q3
$31.2M Sell
176,608
-390
-0.2% -$67.7K 0.01% 978
2016
Q2
$31.8M Sell
176,998
-4,680
-3% -$831K 0.01% 971
2016
Q1
$33.2M Sell
181,678
-16,070
-8% -$2.79M 0.01% 923
2015
Q4
$35.3M Sell
197,748
-208,844
-51% -$36.7M 0.01% 900
2015
Q3
$72.8M Sell
406,592
-28,976
-7% -$5.36M 0.03% 595
2015
Q2
$83.3M Buy
435,568
+241,750
+125% +$44.9M 0.03% 587
2015
Q1
$34.5M Sell
193,818
-120,161
-38% -$19M 0.01% 971
2014
Q4
$45.1M Sell
313,979
-12,887
-4% -$1.76M 0.02% 845
2014
Q3
$42.6M Sell
326,866
-257,223
-44% -$32.7M 0.02% 867
2014
Q2
$74.6M Buy
584,089
+261,077
+81% +$30.9M 0.03% 623
2014
Q1
$36.4M Buy
323,012
+9,645
+3% +$1M 0.01% 936
2013
Q4
$32.3M Buy
313,367
+79,201
+34% +$7.76M 0.01% 1004
2013
Q3
$21.9M Buy
234,166
+5,806
+3% +$533K 0.01% 1124
2013
Q2
$19.3M Buy
+228,360
New +$18M 0.01% 1118

Other funds holding HUM

Invesco's HUM Position: Q2 2026 in Review

Invesco reduced its Humana (HUM) stake by 38% in Q2 2026, selling an estimated $258M and leaving 1,478,788 shares worth $587M. The position accounts for 0.05% of the portfolio, ranked #312.

Invesco first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. The position peaked at $665M in Q4 2022. 922 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Invesco held 1,478,788 shares of Humana worth $587M as of Q2 2026.
  • Invesco sold 907,025 Humana shares in Q2 2026, an estimated $258M.
  • Humana made up 0.05% of Invesco's portfolio in Q2 2026, its #312 holding.
  • Invesco first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • Invesco's Humana position peaked at $665M in Q4 2022.
  • 922 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.